Water-soluble sulfonate porphyrin functionalized hyaluronic acid with comb-like structure: Potential photosensitizers for photodynamic therapy
Source abstract
Abstract
Abstract A water-soluble comb-like porphyrin polymer based on hyaluronic acid (HA) as the main chain and sulfonate substituted tetraphenylporphyrin (TASP) as side groups, named as HA-g-NH-TPP-(SO3Na) [(HA-g-TASP)], was designed and synthesized, which could be used as a potential photosensitizer in photodynamic therapy (PDT). This photosensitizer displayed high-water solubility, low dark cytotoxicity, high photocytoxiticy and high singlet oxygen yield (ΦΔ = 0.86). The HA-g-TASP was carefully characterized by UV–Vis, FTIR, and 1H NMR. UV–Vis spectra showed the Q bands of the HA-g-TASP spectrum had a significant red shift about 50 nm to near-infrared (NIR) region compared with TASP, the HA-g-TASP had a smaller energy band gap. The NIR region is known as the transparent window of the organisms, NIR irradiation shows larger penetration distance in tissue. As a novel photosensitizer, HA-g-TASP exhibited low cytotoxicity in dark and also low photocytotoxicity towards normal cells, but performed enhanced photodynamic activity against cancer cells (HeLa cells). As a result, HA-g-TASP with comb-like structure may be a useful photosensitizer for practical photodynamic therapy in the future.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Photodynamic therapy of cancer: an update10.3322/caac.20114 ↗
2. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges10.1016/j.jconrel.2013.02.020 ↗
3. Aminolevulinic acid-based tumor detection and therapy: molecular mechanisms and strategies for enhancement10.3390/ijms161025865 ↗
4. Aptamers: active targeting ligands for cancer diagnosis and therapy10.7150/thno.10257 ↗
5. Photodynamic therapy in dermatology: state-of-the-art10.1111/j.1600-0781.2010.00507.x ↗
6. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications-actinic keratoses, Bowen's disease, basal cell carcinoma10.1111/jdv.12031 ↗
7. How does photodynamic therapy work?10.1111/j.1751-1097.1992.tb04222.x ↗
8. Photodynamic therapy and the development of metal-based photosensitisers
9. Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction10.1016/S1572-1000(05)00060-8 ↗
10. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization10.1016/S1572-1000(05)00007-4 ↗
11. Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction10.1016/S1572-1000(05)00060-8 ↗
12. Synthesis of water-soluble and thermoresponsive phthalocyanine ended block copolymers as potential photosensitizer10.1016/j.dyepig.2017.03.010 ↗
13. Phthalocyanines covalently bound to biomolecules for a targeted photodynamic therapy10.2174/092986707780830970 ↗
14. The role of porphyrin chemistry in tumor imaging and photodynamic therapy10.1039/B915149B ↗
15. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy10.1111/j.1751-1097.2009.00585.x ↗
16. Tumor-targeting nanogel that can function independently for both photodynamic and photothermal therapy and its synergy from the procedure of PDT followed by PTT10.1016/j.jconrel.2013.07.006 ↗
17. Porphyrin- or phthalocyanine-bridged silsesquioxane nanoparticles for two-photon photodynamic therapy or photoacoustic imaging10.1039/C7NR04677D ↗
18. Theranostic liposomes with hypoxia-activated prodrug to effectively destruct hypoxic tumors post-photodynamic therapy10.1021/acsnano.6b07525 ↗
19. Metal-organic framework nanoparticles in photodynamic therapy: current status and perspectives10.1002/adfm.201606314 ↗
20. Dendrimer generation effects on photodynamic efficacy of dendrimer porphyrins and dendrimer-loaded supramolecular nanocarriers10.1021/cm071451m ↗
21. Porphyrin shell microbubbles with intrinsic ultrasound and photoacoustic properties10.1021/ja305988f ↗
22. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents10.1038/nmat2986 ↗
23. Stimuli-responsive photoacoustic nanoswitch for in vivo sensing applications10.1021/nn502858b ↗
24. Enzymatic regioselection for the synthesis and biodegradation of porphysome nanovesicles10.1002/anie.201108280 ↗
25. Self-assembled chlorin e6 conjugated chondroitin sulfate nanodrug for photodynamic therapy10.1021/bm200115v ↗
26. Doxorubicin loaded singlet-oxygen producible polymeric micelle based on chlorine e6 conjugated pluronic F127 for overcoming drug resistance in cancer10.1016/j.biomaterials.2014.05.063 ↗
27. The controlled photoactivity of nanoparticles derived from ionic interactions between a water soluble polymeric photosensitizer and polysaccharide quencher10.1016/j.biomaterials.2011.07.023 ↗
28. Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells10.1021/bc100116v ↗
29. Hyaluronic acid-based hydrogels: from a natural polysaccharide to complex networks10.1039/c2sm06463d ↗
30. Underhill CCD44: the hyaluronan receptor. J cell sci 103: 293-29810.1242/jcs.103.2.293 ↗
31. A simplified synthesis for meso-tetraphenylporphine. J Org Chem 32:47610.1021/jo01288a053 ↗
32. Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly10.1021/nn3058642 ↗
33. Picosecond laser photophysics. Group 3A phthalocyanines10.1021/ja00521a011 ↗
34. Synthesis and photophysical properties of nonaggregated phthalocyanines bearing dendritic substituents10.1021/ma990367s ↗
35. Singlet oxygen quantum yields of different photosensitizers in polar solvents and micellar solutions10.1002/(SICI)1099-1409(199803/04)2:2<145::AID-JPP60>3.0.CO;2-2 ↗
36. Metallophthalocyanine-based conjugated microporous polymers as highly efficient photosensitizers for singlet oxygen generation10.1002/anie.201501732 ↗
37. Combining ruthenium(II) complexes with metal–organic frameworks to realize effective two-photon absorption for singlet oxygen generation10.1021/acsami.6b05817 ↗
38. A molecular combination of zinc(II) phthalocyanine and tamoxifen derivative for dual targeting photodynamic therapy and hormone therapy10.1021/acs.jmedchem.7b00682 ↗
39. Photodynamic therapy of oligoethylene glycol dendronized reduction-sensitive porphyrins10.1039/C5TB00276A ↗
40. Red-emitting upconverting nanoparticles for photodynamic therapy in cancer cells under near-infrared excitation10.1002/smll.201201437 ↗
41. Photosensitized singlet oxygen and its applications10.1016/S0010-8545(02)00034-6 ↗
42. Porphyrin-containing amphiphilic block copolymers for photodynamic therapy10.1039/C5PY00039D ↗
43. A molecular combination of Zinc(II) phthalocyanine and tamoxifen derivative for dual targeting photodynamic therapy and hormone therapy10.1021/acs.jmedchem.7b00682 ↗
44. Electrochemical, spectroscopic, and 1O2 sensitization characteristics of synthetically accessible linear tetrapyrrole complexes of palladium and platinum10.1021/acs.inorgchem.7b00796 ↗
45. BODIPY derivatives for photodynamic therapy: influence of configuration versus heavy atom effect10.1021/acsami.7b07569 ↗
46. Synthesis and characterization of aminoporphyrin-end-functionalized poly(N-isopropylacrylamide) with photodynamic and thermoresponsive effects10.1002/asia.201301513 ↗